Jeffrey jacobs goldfinch bio
WebIn his past career he occupied the position of Senior Vice President-Technical Operations at Ardelyx, Inc., Chief Scientific Officer for Goldfinch Bio, Inc., Principal at Affymax, Inc., … WebDec 6, 2024 · Dr. Jacobs graduated magna cum laude with a B.S. in Chemistry from Gonzaga University. He received his Ph.D. in Bioorganic Chemistry from U.C. Berkeley where he started the catalytic antibody...
Jeffrey jacobs goldfinch bio
Did you know?
WebDec 6, 2024 · -- Dr. Jacobs brings expansive small molecule discovery and development leadership expertise, Including experience leading discovery and development strategies for new medicines for kidney disease ---- Goldfinch Bio is advancing precision kidney medicines, including its lead candidate GFB-887, currently in Phase 2 study for the treatment of focal … WebDec 6, 2024 · -- Dr. Jacobs brings expansive small molecule discovery and development leadership expertise, Including experience leading discovery and development strategies for new medicines for kidney disease ...
WebWe're thrilled to announced Jeff Jacobs has joined Goldfinch Bio as ... Chief Scientific Officer, a key addition to our team as we work to advance # precisionmedicines for people …
WebDec 6, 2024 · Jacobs, who most recently served as CSO of Ardelyx, Inc., brings to Goldfinch Bio over 25 years of experience leading drug discovery and development efforts across … WebDec 6, 2024 · CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the appointment of Jeff W. Jacobs, Ph.D. as Chief Scientific Officer (CSO).Dr. Jacobs, who most recently served as CSO of Ardelyx, …
WebJeff Jacobs San Mateo, California, United States 738 followers 500+ connections Join to view profile Activity Ardelyx is thrilled to be participating at the 6th Annual Henry Ford …
WebJacobs was most recently Chief Scientific Officer at Goldfinch Bio, where he led the research and discovery program to help build its portfolio of therapeutics for rare kidney diseases. … blackthorne logisticsWebMar 16, 2024 · Jeffrey Jacobs has been working as a Chief Scientific Officer at Fulcrum Therapeutics for 4 months. Fulcrum Therapeutics is part of the Manufacturing industry, … blackthorn elite seriesWebgoldfinch, any of several species of the genus Carduelis (some formerly in Spinus) of the songbird family Fringillidae; they have short, notched tails and much yellow in the plumage. All have rather delicate sharp-pointed bills … blackthorne lawWebCongrats Jeff in your new role. I am delighted that you joined Goldfinch Bio and look forward to your ongoing contributions as we focus on our mission to bring… foxboro lights christmasWebWork Biography for Jeffrey Jacobs, Fulcrum Therapeutics. Jeffrey Jacobs works as a Chief Scientific Officer at Fulcrum Therapeutics, which is a Pharmaceuticals company with an estimated 104 employees; and founded in 2016. ... They used to work at Ceridian and Goldfinch Bio and have used the following emails: @fulcrumtx.com, @genmills.com ... blackthorne legal supportWebContact Email [email protected] Phone Number (617)337-4200 Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease. blackthorn eliteWebWe're thrilled to announced Jeff Jacobs has joined Goldfinch Bio as Chief Scientific Officer, a key addition to our team as we work to advance #precisionmedicines for people with #kidneydiseases.... blackthorne marina